Literature DB >> 19455406

Obesity and impaired renal function: potential for lifestyle intervention?

Eva Corpeleijn1, Stephan J L Bakker, Ronald P Stolk.   

Abstract

Obesity is recently acknowledged as an important independent risk factor for kidney disease, in which epidemiological evidence played a crucial role. This risk is probably explained by intracellular lipid accumulation in the kidney. Lifestyle factors such as physical activity and diet play a role in the development of kidney disease in several stages: development of obesity and the metabolic syndrome, occurrence of obesity-related glomerulopathy, improvement of hemodialysis patients, and prevention of graft dysfunction and graft loss after renal transplantation. After the recent success of lifestyle intervention to prevent diabetes, further research is needed to show the effects of lifestyle changes to prevent and reduce obesity-related morbidity, including chronic kidney disease.

Entities:  

Mesh：

Year:  2009        PMID： 19455406     DOI： 10.1007/s10654-009-9345-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  45 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Improvements in insulin resistance with aerobic exercise training: a lipocentric approach.

Authors:  Clinton R Bruce; John A Hawley
Journal:  Med Sci Sports Exerc       Date:  2004-07       Impact factor: 5.411

3.  Metabolic syndrome: a fata morgana?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Dick de Zeeuw
Journal:  Nephrol Dial Transplant       Date:  2006-10-18       Impact factor: 5.992

4.  Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact.

Authors:  R J Bosma; A J Kwakernaak; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Am J Transplant       Date:  2007-01-22       Impact factor: 8.086

5.  Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

Authors:  Ronald P Stolk; Judith G M Rosmalen; Dirkje S Postma; Rudolf A de Boer; Gerjan Navis; Joris P J Slaets; Johan Ormel; Bruce H R Wolffenbuttel
Journal:  Eur J Epidemiol       Date:  2007-12-13       Impact factor: 8.082

Review 6.  Obesity and renal hemodynamics.

Authors:  R J Bosma; J A Krikken; J J Homan van der Heide; P E de Jong; G J Navis
Journal:  Contrib Nephrol       Date:  2006       Impact factor: 1.580

7.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Authors:  Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

8.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

9.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 10.  Association between obesity and kidney disease: a systematic review and meta-analysis.

Authors:  Y Wang; X Chen; Y Song; B Caballero; L J Cheskin
Journal:  Kidney Int       Date:  2007-10-10       Impact factor: 10.612
View more
  9 in total

1.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

2.  Cardiovascular events in patients with obesity: an observational study.

Authors:  Francisco Buitrago; Juan Ignacio Calvo; Verónica Redondo-López; Lourdes Cañón-Barroso; Leoncio Rodríguez-Pérez; José Francisco Hinojosa-Díaz
Journal:  Br J Gen Pract       Date:  2010-08       Impact factor: 5.386

3.  New studies, technology, and the progress of epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-12       Impact factor: 8.082

4.  Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet.

Authors:  Kamal A Amin; Hamdy H Kamel; Mohamed A Abd Eltawab
Journal:  Lipids Health Dis       Date:  2011-01-14       Impact factor: 3.876

5.  Maternal smoking during pregnancy and subcutaneous fat mass in early childhood. The Generation R Study.

Authors:  Büşra Durmuş; Lamise Ay; Anita C S Hokken-Koelega; Hein Raat; Albert Hofman; Eric A P Steegers; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2011-01-13       Impact factor: 8.082

6.  The Generation R Study: design and cohort update 2010.

Authors:  Vincent W V Jaddoe; Cock M van Duijn; Albert J van der Heijden; Johan P Mackenbach; Henriëtte A Moll; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-10-22       Impact factor: 8.082

7.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

Review 8.  Cardiovascular and metabolic influences of fetal smoke exposure.

Authors:  Hanneke Bakker; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2011-10-13       Impact factor: 8.082

9.  Protective Role of Aerobic Exercise Against Cisplatin-Induced Nephrotoxicity in Rats.

Authors:  Farzaneh Zeynali; Mehdi Nematbakhsh; Hossain Mojtahedi; Aliasghar Poorshahnazari; Ardeshir Talebi; Zahra Pezeshki; Safoora Mazaheri; Fatemeh Moslemi
Journal:  Asian J Sports Med       Date:  2015-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.